Skip to content
2000
Volume 29, Issue 26
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

The most typical malignant brain tumor, glioblastoma multiforme (GBM), seems to have a grim outcome, despite the intensive multi-modality interventions. Literature suggests that biologically active phytomolecules may exert anticancer properties by regulating several signaling pathways. Berberine, an isoquinoline alkaloid, has various pharmacological applications to combat severe diseases like cancer. Mechanistically, it inhibits cell proliferation and invasion, suppresses tumor angiogenesis, and induces cell apoptosis. The antitumoral effect of berberine in GBM is increasingly recognized. This review sheds new light on the regulatory signaling mechanisms of berberine in various cancers, proposing its potential role as a therapeutic agent for GBM.

Loading

Article metrics loading...

/content/journals/cmc/10.2174/0929867329666220224112811
2022-08-01
2025-07-04
Loading full text...

Full text loading...

/content/journals/cmc/10.2174/0929867329666220224112811
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test